Robert Ekart

ResearcherID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 8

Top Venues

Pharmaceuticals (Basel, Switzerland)

International journal of molecular sciences

Antioxidants (Basel, Switzerland)

Hemodialysis international. International Symposium on Home Hemodialysis

University of Maribor, Medical Faculty (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

University of Maribor, Medical Faculty

Slovenia

PHD

Publications

Luka Varda, Robert Ekart, Mitja Lainscak, Uroš Maver, Sebastjan Bevc
Clinical Properties and Non-Clinical Testing of Mineralocorticoid Receptor Antagonists in In Vitro Cell Models. International journal of molecular sciences 25 (16) (2024)
Luka Varda, Robert Ekart, Mitja Lainscak, Uroš Maver, Sebastjan Bevc
Clinical Properties and Non-Clinical Testing of Mineralocorticoid Receptor Antagonists in In Vitro Cell Models. International journal of molecular sciences 25 (16) (2024)
Nejc Piko, Sebastjan Bevc, Radovan Hojs, Robert Ekart
Finerenone: From the Mechanism of Action to Clinical Use in Kidney Disease. Pharmaceuticals (Basel, Switzerland) 17 (4) (2024)
Nejc Piko, Sebastjan Bevc, Radovan Hojs, Robert Ekart
Finerenone: From the Mechanism of Action to Clinical Use in Kidney Disease. Pharmaceuticals (Basel, Switzerland) 17 (4) (2024)
Nejc Piko, Sebastjan Bevc, Radovan Hojs, Robert Ekart
The Role of Oxidative Stress in Kidney Injury. Antioxidants (Basel, Switzerland) 12 (9) (2023)
Špela Šalamon, Sebastjan Bevc, Robert Ekart, Radovan Hojs, Uroš Potočnik
Polymorphism in the GATM Locus Associated with Dialysis-Independent Chronic Kidney Disease but Not Dialysis-Dependent Kidney Failure. Genes 12 (6) (2021)
Nina Vodošek Hojs, Sebastjan Bevc, Robert Ekart, Nejc Piko, Tadej Petreski, Radovan Hojs
Mineralocorticoid Receptor Antagonists in Diabetic Kidney Disease. Pharmaceuticals (Basel, Switzerland) 14 (6) (2021)
Masa Knehtl, Eva Jakopin, Benjamin Dvorsak, Sebastjan Bevc, Robert Ekart, Radovan Hojs
The effect of high-flux hemodialysis and post-dilution hemodiafiltration on platelet closure time in patients with end stage renal disease. Hemodialysis international. International Symposium on Home Hemodialysis 23 (3) (2019)

Robert Ekart.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Robert Ekart